lundi 30 mars 2015

Major increase in bowel cancer screening uptake shown with new screening test

A large pilot study of a new bowel cancer screening test has demonstrated a major increase in participation rates across population groups. The new test is called a Fecal Immunochemical Test or FIT for short. In addition to being able to detect many more cancers and pre-cancers, the pilot of FIT in 40,000 people in the northwest, midlands and the south of England showed almost double the uptake with FIT than with the current test (guaiac faecal occult blood test or gFOBt) for those who had previously chosen not to participate (14.5 per cent climbed to 25.6 per cent).

Major increase in bowel cancer screening uptake shown with new screening test

Aucun commentaire:

Enregistrer un commentaire